EN  IT

FinTrackNow - Technical Analysis 4DA.F Stock Stock Market's Charts 4DA.F

Overview of OX2 AB (4DA.F)

OX2 AB is a Stock listed on the Frankfurt, trading under the symbol 4DA.F. The asset is currently priced at 4 EUR. This provides an important snapshot of its current market position within the Stock sector.

Market Details for OX2 AB

During the most recent trading session on the Frankfurt, OX2 AB had recently a daily price range from 4 to 4 EUR. These fluctuations are typical for assets in the Stock market and reflect current market conditions.

Daily Activity Stock Chart of 4DA.F on the Frankfurt Market

Throughout the day, OX2 AB has seen price movements ranging from 4 to 4 EUR. This daily volatility reflects the dynamics of the market and the interaction of various market participants. Regular price fluctuations are a standard part of trading for this type of asset on the Frankfurt.

Key Information About OX2 AB

Traded on the Frankfurt, OX2 AB is a significant player in the Stock category. Investors can observe the recent price activity, with the asset trading at 4 EUR and a daily range that has varied between 4 and 4 EUR.

General Considerations for 4DA.F Stock Price

As a listed Stock on the Frankfurt, 4DA.F continues to play a role in daily market activities. Its current price of 4 EUR is supported by a typical trading range, and market participants can observe how external factors may influence its movement during the day. In conclusion, OX2 AB remains a noteworthy Stock on the Frankfurt. Its recent price of 4 EUR, combined with daily highs and lows ranging from 4 to 4 EUR, offers a view of its activity on the exchange.

You may also be interested in:

OX2 AB (4DA.MU) - BIVICTRIX THER.PLC LS-,01 (4DE.F) - BiVictriX Therapeutics PLC (4DE.SG) - Dana Inc. R (4DH.BE) - Dana Inc. R (4DH.DU) - Dana Inc. R (4DH.F) - Denali Therapeutics Inc. R (4DN.BE) - Denali Therapeutics Inc. R (4DN.DU) - Denali Therapeutics Inc. R (4DN.F) - Denali Therapeutics Inc. R (4DN.MU) - Denali Therapeutics Inc. (4DN.SG) - view more...